|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02315 BIOCYTOGEN-B
Nominal 
8.900 +0.190 (+2.181%) | 2023/12 | 2022/12 | 2021/12 | 2020/12 |
Profitability Analysis
| ROAA (%) | -14.591 | -23.594 | -23.571 | -18.401 | |
| ROAE (%) | -39.640 | -50.299 | -40.404 | -29.454 | |
| Return on Capital Employed (%) | -20.459 | -27.439 | -29.392 | -21.425 |
Margin Analysis
| Gross Profit Margin (%) | 70.585 | 73.378 | 69.789 | 65.864 | |
| EBITDA Margin (%) | -12.618 | -67.152 | -110.060 | -164.321 | |
| Pre-tax Profit Margin (%) | -53.027 | -112.638 | -153.895 | -188.013 | |
| Net Profit Margin (%) | -53.417 | -112.749 | -153.876 | -168.844 |
Liquidity Analysis
| Current Ratio (X) | 1.252 | 1.517 | 1.958 | 3.494 | |
| Quick Ratio (X) | 1.239 | 1.486 | 1.924 | 3.470 |
Leverage Analysis
| Total Liabilities / Total Assets(%) | 67.730 | 58.897 | 45.632 | 37.321 | |
| Total Liabilities / Shareholders' Funds (%) | 211.096 | 143.860 | 84.253 | 59.741 | |
| Non-current Liabilities / Shareholders' Funds (%) | 137.597 | 90.989 | 48.448 | 37.141 | |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A |
Efficiency Analysis
| Inventory Turnover on Sales (Day) | 6.624 | 11.535 | 11.901 | 11.488 |
| Remarks: | Real time quote last updated: 02/05/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -382,951,000 |
| %Change | -36.381% |
| EPS / (LPS) | RMB -0.960 |
| NBV Per Share (¥) | RMB 1.968 |